The potential relationship between CMTM6 and inflammatory or immune response was explored in tumors such as gliomas (20), lung cancer (41, 68, 69), and ovarian cancer (22) by using functional annotation enrichment analysis, gene set enrichment analysis (GSEA), gene set variation analysis (GSVA), and other analytical methods. This evidence concerns the gene CMTM6 and lung carcinoma.